• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

J Virol Methods . SARS-CoV-2: Comparative analysis of different RNA extraction methods

tetano

Editor, Senior Moderator
J Virol Methods


. 2020 Nov 4;114008.
doi: 10.1016/j.jviromet.2020.114008. Online ahead of print.
SARS-CoV-2: Comparative analysis of different RNA extraction methods


Cecilia Ambrosi[SUP] 1 [/SUP], Carla Prezioso[SUP] 2 [/SUP], Paola Checconi[SUP] 3 [/SUP], Daniela Scribano[SUP] 4 [/SUP], Meysam Sarshar[SUP] 5 [/SUP], Maurizio Capannari[SUP] 6 [/SUP], Carlo Tomino[SUP] 3 [/SUP], Massimo Fini[SUP] 7 [/SUP], Enrico Garaci[SUP] 8 [/SUP], Anna Teresa Palamara[SUP] 9 [/SUP], Giovanna De Chiara[SUP] 10 [/SUP], Dolores Limongi[SUP] 3 [/SUP]



Affiliations

Abstract

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the etiologic agent of the COVID-19 pandemic. Although other diagnostic methods have been introduced, detection of viral genes on oro- and nasopharyngeal swabs by reverse-transcription real time-PCR (rRT-PCR) assays is still the gold standard. Efficient viral RNA extraction is a prerequisite for downstream performance of rRT-PCR assays. Currently, several automatic methods that include RNA extraction are available. However, due to the growing demand, a shortage in kit supplies could be experienced in several labs. For these reasons, the use of different commercial or in-house protocols for RNA extraction may increase the possibility to analyze high number of samples. Herein, we compared the efficiency of RNA extraction of three different commercial kits and an in-house extraction protocol using synthetic ssRNA standards of SARS-CoV-2 as well as in oro-nasopharyngeal swabs from six COVID-19-positive patients. It was concluded that tested commercial kits can be used with some modifications for the detection of the SARS-CoV-2 genome by rRT-PCR approaches, although with some differences in RNA yields. Conversely, EXTRAzol reagent was the less efficient due to the phase separation principle at the basis of RNA extraction. Overall, this study offers alternative suitable methods to manually extract RNA that can be taken into account for SARS-CoV-2 detection.

Keywords: Oro- nasopharyngeal swabs; RNA extraction; SARS-CoV-2; rRT-PCR.
 
Back
Top Bottom